Myriam El Gaaloul

Geneve, GE, Switzerland

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 21 publications

Effects of malaria intermittent preventive treatment with dihydroartemisinin-piperaquine on antiretroviral drug concentrations in African pregnant women living with HIV.

Effects of malaria intermittent preventive treatment with dihydroartemisinin-piperaquine on antiretroviral drug concentrations in African pregnant women living with HIV.

Journal: Antimicrobial agents and chemotherapy

Published: June 12, 2026

ICH E21: from landmark guidance to specific action for maternal and child health.

ICH E21: from landmark guidance to specific action for maternal and child health.

Journal: Journal of translational medicine

Published: March 16, 2026

Defining safety parameters for first-trimester malaria treatment trials: stakeholder views from Real-Time Delphi survey.

Defining safety parameters for first-trimester malaria treatment trials: stakeholder views from Real-Time Delphi survey.

Journal: Malaria journal

Published: January 15, 2026

Physiologically-Based Pharmacokinetic Modeling to Investigate Piperaquine Exposure in Pregnant Women Using an Individualized Profile Approach.

Physiologically-Based Pharmacokinetic Modeling to Investigate Piperaquine Exposure in Pregnant Women Using an Individualized Profile Approach.

Journal: Clinical and translational science

Published: October 14, 2025

Improving malaria chemoprevention coverage in pregnancy: Surveying stakeholder preferences for new product profiles and community-delivery approaches across five African countries.

Improving malaria chemoprevention coverage in pregnancy: Surveying stakeholder preferences for new product profiles and community-delivery approaches across five African countries.

Journal: PLOS global public health

Published: September 02, 2025

Correction: Chemoprevention of malaria with long-acting oral and injectable drugs: an updated target product profile.

Correction: Chemoprevention of malaria with long-acting oral and injectable drugs: an updated target product profile.

Journal: Malaria journal

Published: November 29, 2024

PBPK-Led Assessment of Antimalarial Drug Concentrations in Breastmilk: A Strategy for Optimal Use of Prediction Methods to Guide Decision Making in an Understudied Population.

PBPK-Led Assessment of Antimalarial Drug Concentrations in Breastmilk: A Strategy for Optimal Use of Prediction Methods to Guide Decision Making in an Understudied Population.

Journal: CPT: pharmacometrics & systems pharmacology

Published: August 29, 2024

Chemoprevention of malaria with long-acting oral and injectable drugs: an updated target product profile.

Chemoprevention of malaria with long-acting oral and injectable drugs: an updated target product profile.

Journal: Malaria journal

Published: May 08, 2024

Addressing health equity for breastfeeding women: primaquine for Plasmodium vivax radical cure.

Addressing health equity for breastfeeding women: primaquine for Plasmodium vivax radical cure.

Journal: Malaria journal

Published: May 02, 2024

Safety and efficacy of dihydroartemisinin-piperaquine for intermittent preventive treatment of malaria in pregnant women with HIV from Gabon and Mozambique: a randomised, double-blind, placebo-controlled trial.

Safety and efficacy of dihydroartemisinin-piperaquine for intermittent preventive treatment of malaria in pregnant women with HIV from Gabon and Mozambique: a randomised, double-blind, placebo-controlled trial.

Journal: The Lancet. Infectious diseases

Published: October 02, 2023

Randomized, placebo-controlled, double-blind phase I trial of co-administered pyronaridine and piperaquine in healthy adults of sub-Saharan origin.

Randomized, placebo-controlled, double-blind phase I trial of co-administered pyronaridine and piperaquine in healthy adults of sub-Saharan origin.

Journal: Clinical and translational science

Published: August 24, 2023

Ganaplacide (KAF156) plus lumefantrine solid dispersion formulation combination for uncomplicated Plasmodium falciparum malaria: an open-label, multicentre, parallel-group, randomised, controlled, phase 2 trial.

Ganaplacide (KAF156) plus lumefantrine solid dispersion formulation combination for uncomplicated Plasmodium falciparum malaria: an open-label, multicentre, parallel-group, randomised, controlled, phase 2 trial.

Journal: The Lancet. Infectious diseases

Published: January 19, 2023

Showing 1-12 of 21

Last Updated: 09/26/2026